# Momentum-selective graphene spectroscopy of moiré excitons

Preprint · Katsunori Wakabayashi

- Archive id: arxiv:2610.33989
- Published: 2026-10-25
- arXiv: https://arxiv.org/abs/2610.33989
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.33989
- PDF: https://arxiv.org/pdf/2610.33989
- Provenance: arxiv

## Abstract

Far-field photoluminescence probes only the light-cone corner of an exciton's momentum content, whereas energy transfer to nearby graphene integrates in-plane momenta up to the inverse spacer thickness $1/z$. For a WSe$\_2$/MoSe$\_2$ heterobilayer we build the transition polarization $\\bm{P}\_n(\\qv)$ of each localized moiré exciton from the registry-dependent vector dipole texture and use each $\\bm{P}\_n$ for both baths. The two baths rank the states differently: the graphene-rate ratios differ from the optical ones, their ordering inverts with spacer thickness, and the distance exponents at $z=10$\\,nm spread by more than two units. These ratios are independent of the transition-dipole prefactor. Within the $C\_3$-symmetric leading-harmonic model the chiral $p\_+$ and $d\_-$ states are also dark at normal incidence yet transfer to graphene at rates comparable to the bright ground state. Their graphene rate depends on the sign of the texture phase, a quantity invisible in far-field emission, which we determine from first principles. In a device this prediction requires a splitting, larger than the symmetry-breaking mixing, that protects the chiral partners. Graphene proximity thus acts as a momentum-selective near-field probe of moiré excitons, and we propose its use as a practical spectroscopy.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [2D Materials & Van der Waals Heterostructures](https://space-kitty.com/topics/2d-materials)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.